Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
D001665:Binding Sites; D001777:Blood Coagulation / Q000187:drug effects; D002697:Chloral Hydrate / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D004357:Drug Synergism; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced* / Q000517:prevention & control; D008297:Male; D011485:Protein Binding; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D012709:Serum Albumin / Q000378:metabolism; D014238:Trichloroacetic Acid / Q000097:blood / Q000378:metabolism; D014859:Warfarin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*
D012709:Serum Albumin; D002697:Chloral Hydrate; D014859:Warfarin; D014238:Trichloroacetic Acid; D011516:Prothrombin